ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization

Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, Angela Dispenzieri, Rodney H. Falk, Victor A. Ferrari, Marianna Fontana, Olivier Gheysens, Julian D. Gillmore, Andor W.J.M. Glaudemans, Mazen A. Hanna, Bouke P.C. Hazenberg, Arnt V. Kristen, Raymond Y. Kwong, Mathew S. Maurer, Giampaolo Merlini, Edward J. Miller, James C. Moon, Venkatesh L. Murthy, C. Cristina QuartaClaudio Rapezzi, Frederick L. Ruberg, Sanjiv J. Shah, Riemer H.J.A. Slart, Hein J. Verberne, Jamieson M. Bourque

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.

Original languageEnglish (US)
Pages (from-to)854-865
Number of pages12
JournalJournal of Cardiac Failure
Volume25
Issue number11
DOIs
StatePublished - Nov 2019

Keywords

  • Cardiac amyloidosis
  • appropriate use
  • diagnosis
  • expert consensus
  • multimodality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization'. Together they form a unique fingerprint.

Cite this